Hypothesis

6 Matching Annotations

Aug 2025
www.sciencedirect.com www.sciencedirect.com

Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells

1
1. scibot 13 Aug 2025
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.medj.2025.100804
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
Visit annotations in context

Tags

RRID:AB_2564127

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666634025002314
May 2025
www.sciencedirect.com www.sciencedirect.com

Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity

1
1. scibot 19 May 2025
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.xpro.2025.103810
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
Visit annotations in context

Tags

RRID:AB_2564127

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666166725002163
Apr 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays

1
1. scibot 18 Apr 2025
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.xpro.2025.103742
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
Visit annotations in context

Tags

RRID:AB_2564127

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12002649/
Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

2
1. scibot 11 Oct 2023
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
2. scibot 01 Oct 2023
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
Visit annotations in context

Tags

RRID:AB_2564127

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10558812/
Aug 2022
www.sciencedirect.com www.sciencedirect.com

Off-The-Shelf Third-Party HSC-Engineered iNKT Cells for Ameliorating GvHD While Preserving GvL Effect in the Treatment of Blood Cancers

1
1. scibot 17 Aug 2022
  
  in Public
  
  RRID:AB_2564127
  
  DOI: 10.1016/j.isci.2022.104859
  
  Resource: (BioLegend Cat# 363005, RRID:AB_2564127)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2564127
  
  What is this?
  
  RRID:AB_2564127
Visit annotations in context

Tags

RRID:AB_2564127

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004222011312